Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Ceftobiprole medocaril

Generic Name: Ceftobiprole medocaril

Brand Names: Zevtera

Drug Type: Small Molecule

Chemical Formula: C_₂₆H_₂₆N_₈O_₁₁S_₂

CAS Number: 376653-43-9

Unique Ingredient Identifier: YXV28V1B07

Overview

Ceftobiprole medocaril is a ceftobiprole prodrug.

Background

Ceftobiprole medocaril is a ceftobiprole prodrug.

Indication

No indication information available.

Associated Conditions

Pneumonia

Clinical Trials

Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age

Phase 3

Completed

Posted: 2023/05/12

Sponsor:Basilea Pharmaceutic...

ID:NCT05856227

Collection of Data of Ceftobiprole Treated Patients: Comparison of Patients With and Without Certain Diseases

Completed

Posted: 2019/11/20

Sponsor:

Advanz Pharma

ID:NCT04170309

Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia

Phase 3

Completed

Posted: 2018/02/20

Sponsor:Basilea Pharmaceutic...

ID:NCT03439124

Open and Exploratory Trial to Investigate the Pharmacokinetic of Ceftobiprole Medocaril in Patients With CSF Device

Phase 2

Completed

Posted: 2017/10/23

Sponsor:Centre Hospitalier U...

ID:NCT03317093

Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia

Phase 3

Completed

Posted: 2017/05/03

Sponsor:Basilea Pharmaceutic...

ID:NCT03138733

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy